Yep, I recon you might be right. Name change with the sp under pressure - not good. People lazy and won't keep track of MBE/IMS. However, if management do turn this around, then happy days. Will continue to watch and wait.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%